Dosage And Administration
TO OPEN: USE TOP OF CAP TO TWIST OFF SEAL.
FOR VAGINAL USE ONLY.
Relegard
FDA Label NDC 51674-0130
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Blansett Pharmacal Co for the product Relegard (NDC 51674-0130). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding dosage and administration, other, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Other
CONTAINS: GLACIAL ACETIC ACID 0.9%, OXYQUINOLINE 0.025%, PRESERVATIVE, GLYCERIN, LACTIC ACID BUFFER, POLYETHYLENE GLYCOL 4500 AND PURIFIED WATER. THE PH OF 3.8 - 4.3 IS ADJUSTED USING 1N POTASSIUM HYDROXIDE.
DO NOT USE IF TAMPER-RESISTANT SEAL AT OPENING HAS BEEN DISTURBED OR IS NOT VISIBLE. IF THIS SEAL HAS BEEN PUNCTURED OR IS NOT VISIBLE, RETURN PRODUCT TO PLACE OF PURCHASE.
STORE AT ROOM TEMPERATURE.
DO NOT TAKE BY MOUTH OR USE IN EYES.
COMPLETE PRESCRIBING INFORMATION IS ENCLOSED.
THIS BOX CONTAINS ONE APPLICATOR.
* Please review the disclaimer below.
